LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000037 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 2, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
15,000
Total Value
$1,267,574.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 5,000 | $52.27 | $261,350.00 | 46,382 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Sale | 460 | $198.85 | $91,470.68 | 45,922 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Sale | 1,302 | $199.72 | $260,038.17 | 44,620 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Sale | 1,238 | $200.94 | $248,767.31 | 43,382 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Sale | 700 | $201.90 | $141,327.97 | 42,682 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Sale | 963 | $203.22 | $195,702.59 | 41,719 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Apr 1, 2026 | Sale | 337 | $204.50 | $68,917.38 | 41,382 | Direct | โ | View Details | |
CLO & Secretary | Employee Stock Option (right to buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 49,444 | Direct | โ | View Details |